$1.01
-0.04-3.81%
At close: -
$0.9700
-0.04-3.96%
After Hours: Dec 20, 7:57 PM EDT
Comments
Loading...
Bone Biologics (NASDAQ:BBLG) Stock, Earnings Estimates, EPS, And Revenue
Bone Biologics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 19
EPS Estimate
$-0.650
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Bone Biologics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Bone Biologics (BBLG) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-2.37 | $-0.60 | -295.0 % |
| Jun 2024 | 2024-08-09 | $-0.67 | $-1.39 | 51.8 % |
| Mar 2024 | 2024-05-14 | $-1.31 | $-7.60 | 82.8 % |
| Dec 2023 | 2024-02-21 | $-29.33 | $-7.60 | -285.9 % |
Bone Biologics (BBLG) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Bone Biologics (NASDAQ:BBLG) reporting earnings?
Bone Biologics (BBLG) is scheduled to report earnings on February 19, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Bone Biologics (NASDAQ:BBLG)?
The Actual EPS was $-2.37, which missed the estimate of $-0.60.
What were Bone Biologics’s (NASDAQ:BBLG) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.